Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
PDS0101 + Pembrolizumab for Head and Neck Cancer
Recruiting1 awardPhase 2
Rochester, Minnesota
This trial is studying PDS0101 in combination with pembrolizumab to treat patients with HPV16 and PD-L1 positive recurrent or metastatic head and neck squamous cell carcinoma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service